AQW 29647/17-22

Ms Paula Bradshaw
Alliance Party
South Belfast

Tabled Date: 11/02/2022
Answered On Date: 22/02/2022
Priority Written: No

Question:
To ask the Minister of Health what consideration has been given to making bronchiestasis a qualifying condition for pre-emptive access to the anti-viral drugs.

Answer:

The eligible groups of highest risk patients to receive the new COVID-19 treatments have been determined by an independent expert group commissioned by the Department of Health and Social Care in England, and included in a clinical policy agreed by all four Chief Medical Officers in the UK. This policy was developed based on evidence that certain health conditions can make a patient much more likely to progress to severe disease. A summary of the health conditions at highest risk from COVID-19 and therefore eligible for direct treatment by a health Trust, is provided at NI Direct Treatments for coronavirus (COVID-19).